New Variant BA.2.86, Vaccine Effectiveness, and Ongoing Discussions

Discussion on the newly announced BA.2.86 variant by WHO, its spike protein mutations, CDC's risk assessment, and the expected efficacy of updated vaccines. Also touches on the classification debate of the variant and mentions other COVID-related stories.